Open Access System for Information Sharing

Login Library

 

Article
Cited 15 time in webofscience Cited 18 time in scopus
Metadata Downloads
Full metadata record
Files in This Item:
There are no files associated with this item.
DC FieldValueLanguage
dc.contributor.authorShaykhalishahi, Hamed-
dc.contributor.authorYazdanparast, Razieh-
dc.contributor.authorHa, Hyung-Ho-
dc.contributor.authorChang, Young-Tae-
dc.date.accessioned2018-06-15T05:13:34Z-
dc.date.available2018-06-15T05:13:34Z-
dc.date.created2017-09-08-
dc.date.issued2009-11-
dc.identifier.issn0014-2999-
dc.identifier.urihttps://oasis.postech.ac.kr/handle/2014.oak/50230-
dc.description.abstractAlzheimer's disease is the major cause of senile dementia with the hallmark of beta-amyloid deposition in neurons. Although the main cause(s) of this deposition is not fully understood, however, the wealth of the present literature data supports the pivotal role of reactive oxygen and nitrogen species in both the initiation and progression of beta-amyloid aggregation and deposition. In the present study, we were interested to evaluate the free-radical protecting effect of AA3E2, a triazine derivative with a beta-amyloid-breaking activity, among SK-N-MC neuroblastoma cells exposed to hydrogen peroxide (H2O2) as an exogenous source of free radicals. Exposure of the cells to different doses of AA3E2 (1-16 mu M) for 3 h followed by subsequent exposure to a single dose of H2O2 (mainly 150 mu M) attenuated the extent of superoxide dismutase (SOD) and catalase (CAT) inhibition by H2O2, in a dose dependent manner. Furthermore, significant reduction was observed in the extent of cellular lactate dehydrogenase release, intracellular ROS and the extent of apoptosis among the cells pre-treated with AA3E2. Based on these data, an antioxidant mode of action is proposed for AA3E2 besides its previously beta-amyloid-breaking activity. (C) 2009 Elsevier B.V. All rights reserved.-
dc.languageEnglish-
dc.publisherELSEVIER SCIENCE BV-
dc.relation.isPartOfEUROPEAN JOURNAL OF PHARMACOLOGY-
dc.subjectPEROXIDE-INDUCED APOPTOSIS-
dc.subjectBETA-PROTEIN TOXICITY-
dc.subjectALZHEIMERS-DISEASE-
dc.subjectHYDROGEN-PEROXIDE-
dc.subjectOXIDATIVE STRESS-
dc.subjectPC12 CELLS-
dc.subjectA-BETA-
dc.subjectAGGREGATION-
dc.subjectANTIOXIDANT-
dc.subjectPEPTIDE-
dc.titleInhibition of H2O2-induced neuroblastoma cell cytotoxicity by a triazine derivative, AA3E2-
dc.typeArticle-
dc.identifier.doi10.1016/j.ejphar.2009.07.017-
dc.type.rimsART-
dc.identifier.bibliographicCitationEUROPEAN JOURNAL OF PHARMACOLOGY, v.622, no.1-3, pp.1 - 6-
dc.identifier.wosid000271696800001-
dc.date.tcdate2019-02-01-
dc.citation.endPage6-
dc.citation.number1-3-
dc.citation.startPage1-
dc.citation.titleEUROPEAN JOURNAL OF PHARMACOLOGY-
dc.citation.volume622-
dc.contributor.affiliatedAuthorChang, Young-Tae-
dc.identifier.scopusid2-s2.0-70349409090-
dc.description.journalClass1-
dc.description.journalClass1-
dc.description.wostc14-
dc.type.docTypeArticle-
dc.subject.keywordPlusPEROXIDE-INDUCED APOPTOSIS-
dc.subject.keywordPlusBETA-PROTEIN TOXICITY-
dc.subject.keywordPlusALZHEIMERS-DISEASE-
dc.subject.keywordPlusHYDROGEN-PEROXIDE-
dc.subject.keywordPlusOXIDATIVE STRESS-
dc.subject.keywordPlusPC12 CELLS-
dc.subject.keywordPlusA-BETA-
dc.subject.keywordPlusAGGREGATION-
dc.subject.keywordPlusANTIOXIDANT-
dc.subject.keywordPlusPEPTIDE-
dc.subject.keywordAuthorAlzheimer&apos-
dc.subject.keywordAuthors disease-
dc.subject.keywordAuthorAntioxidant-
dc.subject.keywordAuthorApoptosis-
dc.subject.keywordAuthorHydrogen peroxide-
dc.subject.keywordAuthorSK-N-MC cell-
dc.subject.keywordAuthorTriazine compound-
dc.relation.journalWebOfScienceCategoryPharmacology & Pharmacy-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.relation.journalResearchAreaPharmacology & Pharmacy-

qr_code

  • mendeley

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Views & Downloads

Browse